Cosmetic Ingredient Review Report Status
This article was originally published in The Rose Sheet
Executive Summary
Chart: Data compiled by the Rose Sheet from information in CIR reports following the Expert Panel's Sept. 11-12 meeting.
You may also be interested in...
CIR News In Brief: No Conclusion Reached On PHMB; Endocrine Activity Guidance; More
At its Sept. 11-12 meeting in Washington, the Cosmetic Ingredient Review Expert Panel finalized reports for various protein and peptide ingredient families, among others, and advanced six tentative reports. The panel issued a tentative insufficient data conclusion for broad-spectrum preservative polyaminopropyl biguanide, with concerns about sensitization continuing to weigh on the group.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.